Search

Your search keyword '"Vlachopoulos, Charalambos"' showing total 350 results

Search Constraints

Start Over You searched for: Author "Vlachopoulos, Charalambos" Remove constraint Author: "Vlachopoulos, Charalambos" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
350 results on '"Vlachopoulos, Charalambos"'

Search Results

1. 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)

2. Angiography-derived physiological patterns of coronary artery disease: implications with post-stenting physiology and long-term clinical outcomes

4. Estimated Arterial Stiffness

6. Contributors

7. Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI

9. Newly detected diabetes mellitus patients with acute coronary syndrome have an adverse cardiometabolic profile similar to patients with prior diabetes and a more extensive ischemic myocardial insult

11. Comprehensive Angiography-Derived Functional Assessment of Epicardial and Microvascular Coronary Disease. Correlation With Non-invasive Myocardial Stress Imaging

14. Time-related aortic inflammatory response, as assessed with 18F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19: the COVAIR study

15. A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019

19. Effects of Chemotherapy on Aortic 18-Fluorodeoxyglucose Uptake in Patients With Hodgkin and Non-Hodgkin Lymphoma

24. Clusters of risk factors in metabolic syndrome and their influence on central blood pressure in a global study

35. The Effect of Surgical Aortic Valve Replacement on Arterial Stiffness: Does the Valve Type Matter?

37. Contributors

39. Tribute to Michael O'Rourke (1937–2024): A Collective Tribute to a Colleague, Friend and Mentor.

40. Effect of FluoRoquinolones on Aortic Growth, aortic stIffness and wave refLEctionS (FRAGILES study).

41. Expression of Circulating miR-21 and -29 and their Association with Myocardial Fibrosis in Hypertrophic Cardiomyopathy

46. Twenty-Four–Hour Central (Aortic) Systolic Blood Pressure: Reference Values and Dipping Patterns in Untreated Individuals

47. Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis

48. Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis.

49. Management of Patients With Unexplained Syncope: Derivation and Validation of a Simplified 2‐Step Diagnostic Approach

50. Extremely high-risk patients with acute coronary syndrome: How “extreme” should lipid-lowering therapy be if the LDL-C target <40 mg/dl is considered?

Catalog

Books, media, physical & digital resources